sentation had shown no progression, and the patient was followed up thereafter with annual MRI. Four years prior to the current presentation, we had noted progression in the high-intensity lesion on FLAIR imaging without enhancement on T1-weighted imaging (Fig. 2 ). An astrocytoma had been suspected, and our department had been consulted to consider biopsy for a definitive diagnosis. However, the patient had no complaints at that time, and no further invasive tests or treatments were conducted. No neurological impairment was observed until 3 months prior to the current presentation, and follow-up MRI had shown slow progression of the lesion. She then began to develop dysarthria and impaired short-term memory. These symptoms progressed, and she finally presented to our emergency department. Computed tomography revealed a novel hemorrhagic lesion in the right frontal lobe (Fig. 3A) . Magnetic resonance imaging showed that the previously observed lesion in the left frontotemporal lobe and basal ganglia had further progressed (Fig. 3B ), but no enhancement was observed on T1-weighted imaging (Fig.  3C ). We started conservative treatment for the right frontal hemorrhage, and on day 30, we performed partial left temporal lobectomy to obtain a definitive diagnosis.
Operation and Pathological Findings
With the patient under general anesthesia, a left frontotemporal curvilinear skin incision was made and a small frontotemporal craniotomy was performed. After the dural incision, a corticotomy was performed within the inferior temporal gyrus, and partial lobectomy for the left temporal lesion was conducted toward the temporal base. After removal of the lesion, including the temporal tip, the dura mater was closed and the bone was fixed with titanium plates. Finally, the skin wound was closed. A specimen of the left temporal lobe was sent out for pathological examination (Fig. 4) , and the diagnosis of diffuse astrocytoma was made.
Postoperative Course
The patient underwent postoperative rehabilitation. On day 65, follow-up MRI revealed novel gadoliniumenhanced lesions around the right carotid foramen (Fig.  5A ), in the left parahippocampal gyrus (Fig. 5B) , and in the right frontal lobe within the previous hemorrhagic lesion (Fig. 5C ). Given the patient's history of lung cancer, we performed contrast-enhanced CT on day 70 because of suspected brain metastasis and primary lung lesion. A novel enhanced lesion in the right cervical lymph node ( ment. On day 85, we performed thoracocentesis for the left pleural effusion (Fig. 7A and B) , and cytological examination of the pleural effusion revealed no atypical cells. On day 86, a chest drainage tube was placed by our pulmonologist for repetitive accumulation of the left pleural effusion, and continuous drainage of the pleural effusion was started (Fig. 7C) . The patient's impaired respiratory status continued to worsen with intractable accumulation of pleural fluid, and cytological examination of the massive pleural effusion was repeated on day 89. The specimen exhibited malignant cells showing an increased nucleus/cytoplasm ratio, nuclear pleomorphism, and hyperchromatic nuclei (Fig. 8) , and we suspected a small round cell tumor such as lymphoma. On day 93, we collected another specimen of the massive pleural effusion and examined it using the cell block technique. On day 94, the patient's respiratory status further worsened despite continuous pleural fluid drainage, and she died. After her death, glioblastoma was diagnosed using the cell block specimen of pleural effusion (Fig. 9) , which showed the following characteristics: glial fibrillary acidic protein (GFAP; +), epithelial membrane antigen (-), AE1/AE3 (-), leukocyte common antigen (LCA; -), S100 (-), CD56 (+), synaptophysin (-), and chromogranin A (-).
Discussion Extracranial Glioblastoma and Its Increased Incidence
Several studies have revealed the involvement of multiple organs, including the lung and pleura, in patients with metastatic glioblastoma. 2, 6, [15] [16] [17] [18] [19] Patients in these studies were mainly diagnosed by histological examination of biopsy specimens. The incidence of extracranial glioblastoma is considered to be increasing. 8, 12, 18 The mean survival time of patients with glioblastoma is very short, while systemic metastasis seems to take a considerable period of time to emerge. Recent treatments such as temozolomide can contribute to prolonging survival time, 7 ,14 but such therapy may also contribute to the prolonged development of circulating malignant cells and thus the increased incidence of extracranial metastasis of glioblastoma. Therefore, early diagnosis and treatment would improve the clinical course of such patients.
Diagnosis of Metastatic Lung and Pleural Glioblastoma
A previous study showed that the lung and pleura are two of the most frequent sites of systemic metastasis of glioblastoma. 8, 12 Chivukula et al. 2 described a patient with extracranial glioblastoma diagnosed by fine needle aspiration biopsy. In that report, the patient had a mass in the upper lobe of the right lung, and malignant cells were found on examination of a specimen from that mass but not on examination of the bronchoalveolar lavage fluid or pleural fluid. In the present case, the first cytological analysis using pleural effusion obtained by thoracocentesis was also negative, but repeated examination revealed the presence of glioblastoma cells in the pleural effusion. Thus, in patients with glioma, progressive accumulation of pleural fluid warrants repeated cytological examination to increase its sensitivity.
Difficulty of Diagnosing Malignant Disease by Cytological Analysis
Several reports have documented the difficulty of diagnosing glioblastoma cells by cytological analysis 2,11 and the possibility of misinterpreting glioblastoma cells as poorly differentiated non-small cell lung carcinoma cells because both are often small with hyperchromatic nuclei, an increased nucleus/cytoplasm ratio, and prominent pleomorphism.
1, 5 These reports have also demonstrated the significance of immunostaining these cells, which show the following immunostaining profile: GFAP (+), cytokeratin (-), chromogranin (-), and LCA (-). In the present case, cytological analysis of the pleural fluid cells suggested a small round cell tumor, making the diagnosis difficult. However, our cytological examination also showed the following immunostaining profile: GFAP (+), cytokeratin (-), chromogranin (-), and LCA (-). These findings made the diagnosis of glioblastoma reasonable.
Usefulness of the Cell Block Technique for Low-Density Specimens
The cell block technique reportedly increases the sensitivity of cytological analysis by decreasing cellular dispersion when using fluid specimens such as pleural and peritoneal effusions. 10, 13, 21 Wardeh et al. 20 also described the usefulness of this technique when no abnormality had been detected by imaging studies such as CT. Indeed, our patient had no apparent intrathoracic lesion on CT, but the technique still revealed the presence of glioblastoma cells in a pleural sample. Our patient's impaired respiratory status rapidly progressed in a very short time. Earlier diagnosis might have contributed to initiation of earlier treatment and improvement in the clinical course.
Conclusions
In patients with a history of glioma, the presence of extremely intractable pleural effusion may suggest pleural or lung metastasis. In such patients, immediate diagnosis by cytological analysis of pleural effusion using the cell block technique should be considered to initiate appropriate chemotherapy regardless of the positive or negative results of imaging studies. 
